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Early detection of long term conditions is predicated on assumptions that lifestyle changes and medi-
cations can be used to reduce or manage the risk of condition progression. However, ambiguity remains
about the nature and place of diagnostic disclosure to people in newly recognised or asymptomatic ‘pre’
conditions such as early stage chronic kidney disease (CKD). The disclosure of a diagnosis is relevant to
instigating strategies which rely on actively engaging patients as self-managers of their own care. Whilst
primary care routinely records a diagnosis of early stage CKD, little is known about how patients learn
about the fact that they have CKD or how they respond to this. This study aimed to explore patients'
experiences of disclosure of CKD in primary care settings.
A nested qualitative study of participants recruited to a trial of an intervention for CKD patients in
Greater Manchester, UK was undertaken. A purposive sample of 26 patients, with a mean age of 72 years
(range 59e89, median 71), were interviewed during 2012. Interview transcripts were analysed using
constant comparative techniques. Narrative accounts reﬂected limited or partial disclosure of CKD; often
cast in vague terms as “nothing to worry about”. How patients described themselves in terms of
participation and their tendencies towards ‘active’ or ‘passive’ involvement in consultations emerged as
important components of narratives around disclosure. The ﬁndings illuminate the ways in which
diagnosis is oriented in a context where it is possible to meet the requirements for remuneration under a
pay for performance system of primary care, whilst apparently not disclosing a label or a diagnosis to
patients. This challenges the presumptions inherent in wider health policy objectives that are increas-
ingly built on the notion of responsible patients and the ethos of the active support of self-management
for pre-conditions.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Improving population health through early detection of ‘pre-
conditions’ has been linked both to the increased effectiveness of.ac.uk (G. Daker-White), A.E.
.ac.uk (A. Kennedy), Tom.
n.blickem@manchester.ac.uk
Graham).
Ltd. This is an open access article usecondary prevention and the risks of increased surveillance
(Howson, 1998). In the United Kingdom (UK), health policy has
incentivised surveillance of early stage chronic kidney disease
(CKD) in primary care with the detection, recording on a register
and monitoring of CKD constituting remunerated Quality and
Outcomes Framework (QOF) indicators (eGuidelines.co.uk, 2014).
However, little attention has been paid to the ways in which
‘diagnosis,’ or the recording of pre-conditions, is managed in
practice, nor the extent to which disclosure might be considered by
(and have implications for) patients. In this article, we explorender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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within a randomised, controlled trial (RCT) of a self-management
intervention for early stage CKD (Blickem et al., 2013). The inter-
vention consisted of information about kidney health and
telephone-guided access to community support groups and activ-
ities. Given that early stage CKD is currently contested in the
biomedical literature, it was felt valuable to explore diagnostic
awareness within the context of an intervention designed to pro-
vide information about, and open up options for, self-management.
The aim of the trial intervention was to contribute to the evidence-
base for guided self-management, and ﬁts with current notions of
patient empowerment and peer support. Here, we explore patient
experiences of the disclosure of a CKD diagnosis.
Enacting long term condition self-management is a growing
normative expectation of individuals, with primary care seen as
playing a mediating role in its' promotion (Dennis et al., 2008). The
sharing and disclosure of a diagnosis is likely to be a fundamental
pre-condition for transferring management options from health
professional to a person livingwith a long term condition. However,
on the face of it, this is a taken for granted aspect of the process. For
example, the UK Department of Health (2012) consultation docu-
ment, “No decision about me, without me” lays out what should
happen before or after diagnosis, but ‘diagnosis’ itself appears as a
black box process that does not seemingly involve ‘sharing’ or
interaction between doctor and patient.
Disclosure of medical information has traditionally been seen as
a potential source of conﬂict in the doctorepatient relationship
(Faden et al. 1981) where a diagnosis is not always agreed upon
between the two parties (Bugge et al. 2006). In a study of
concealment around cancer diagnosis in Italy, Gordon and Paci
(1997) identiﬁed three sociological themes related to non-
disclosure and biomedical ethics underpinning the “social
embeddeddness” of non-disclosure “practices”: authoritarianism,
“a strong ethic of not causing suffering in others” and the “habitus
of bioethical practice.” They suggested that “giving reassurance is
more important than telling the truth.” In their survey work, they
found an association between non-disclosure and increased patient
age.
In primary care, lifestyle advice related to reducing blood
pressure, drug treatments and monitoring are the recommended
CKD management strategies (De Lusignan et al. 2011). According to
UK guidelines from the National Institute for Health and Care
Excellence (NICE), “People with chronic kidney disease should have
the opportunity to make informed decisions about their care and
treatment, in partnership with their healthcare professionals”
(NICE National Collaborative Centre for Chronic Conditions, 2008:
6). Models of clinical decision-making have traditionally been
characterised as paternalistic or involving either ‘informed choice’
or shared decision-making (Elwyn et al., 1999). Models of patient
preferences in decision-making commonly distinguish between
‘active’ and ‘passive’ patients with implied variations according to
stage in the life course (Kiesler and Auerbach, 2006). A propensity
to involve patients in decision making may differ according to cli-
nicians' perceptions of when circumstances or conditions might be
complex and burdensome for patients. Chronic kidney disease is
more common in people with multiple chronic conditions, espe-
cially diabetes and other vascular diseases (Fraser et al., 2012).
Accordingly, some GPs might be concerned about over burdening
patients with diagnoses or treatments, especially in the context of a
(pre) conditionwhich is likely to be asymptomatic or even seen as a
normal part of the ageing process (Crinson et al., 2010; Moynihan
et al., 2013; Taal, 2012).
Trachtenberg et al. (2005) found that trust was a key predictor of
the degree to which a US sample of patients were involved in their
own care. However, more trusting elderly patients also tended to bemore passive in clinical consultations. In the social science litera-
ture, an imperative for trust assumes salience in situations where
uncertainty and a level of risk coalesce because of the dependence
on the motives, intentions and future action of the other person on
whom the individual depends. Thus, ‘trust’ embraces a combina-
tion of conﬁdence in competence and a judgement as to whether
the ‘trustee’ (e.g. the GP) is judged to be working in the interests of
the ‘trustor’ (e.g. the patient) (after Calnan and Sanford, 2004;
Gilson, 2003; Mishra, 1996).
Some General Practitioners have expressed reservations as to
whether CKD really constitutes a disease and reported difﬁculty
and anxiety in explaining and disclosing the condition to patients
(Crinson et al., 2010; Blakeman et al., 2012). Thus, the ability to
disclose a diagnosis for remuneration purposes and variations in
clinical practice are likely to underlie the communication of diag-
nostic disclosure. However, little is known about the patient
perspective in CKD diagnosis or their views of ‘disclosure’ in this
context. The aim of this study was to explore the diagnostic
awareness of patients with stage 3 CKD who were recruited to an
RCTof a self-management intervention consisting of lifestyle advice
and “guided help” around blood pressure control.
2. Screening, disease registers and CKD: incentivising ‘quality’
in UK primary health care provision?
In 2004 the new NHS contract for GP services in the UK incor-
porated ‘QOF’ as an integral component in an attempt to improve
some aspects of care quality via recording of “146 largely evidence-
based indicators” (Lester et al., 2006). Important elements of the
QOF include the use of templates for the delivery of care and pay-
ment for performance in respect of clinical work adhering to these
templates. In 2006, CKD indicators and templates were ﬁrst intro-
duced into the QOF. For 2013/14, the indicators for which practices
receive QOF ‘points’ are maintaining a register of adults with CKD
Stages 3e5; blood pressure control of patients on the register; the
percentage of patients on the register with hypertension and pro-
teinuria who receive recommended treatments; and annual testing
of patients on the register for protein:creatinine ratio
(eGuidelines.co.uk, 2014).
For the purposes of the ﬁndings presented here, it is worth
stressing that practices do not receive ﬁnancial incentives for
telling patients that they have been placed on the CKD register.
Given the ambiguities and anxieties around CKD management
mentioned above, there appears the potential for a disconnect
between the self-management aspects of care quality and the ‘ev-
idence-based’ aspects of QOF templates and incentives. On the face
of the CKD QOF indicators, it would appear that patients would be
more likely to be aware of their CKD diagnosis if they were being
medically managed for concomitant hypertension and/or protein-
uria. Patients with or without CKD are routinely monitored for
blood pressure readings in primary care and other medical settings
however, and thus whether patients might link blood pressure
monitoring alone to a (potential) CKD diagnosis seems on the face
of it unclear.
3. The diagnosis and treatment of CKD in primary care
Three important features underlie the diagnosis and manage-
ment of CKD in general practice of relevance to a study of patients
with CKD stage 3. Firstly, the classiﬁcation of CKD stages is a rela-
tively new phenomenon (CKD is staged from 1 to 5, although stage
3 is sub-divided into 3a and 3b). Secondly, there has been debate
and controversy, both about the staging classiﬁcation in general
and about its utility in the clinical management of elderly people in
particular. Thirdly, and following from the preceding section, the
G. Daker-White et al. / Social Science & Medicine 131 (2015) 31e39 33introduction of payments for recording of CKD indicators creates
the potential for GPs to be incentivized for undertaking actions
(such as blood pressure control in the elderly) that might conﬂict
with usual clinical practice.
A new CKD staging system was ﬁrst developed by the US Na-
tional Kidney Foundation in 2002 (Polkinghorne, 2011). Armstrong
(2011) outlines how GPs have historically been instrumental in
shaping disease classiﬁcations, which have the potential to both
“structure and contain” care. In this context, one could point to a
potential for GPs to (re)shape a classiﬁcation system (e.g. as
derived by expert review of evidence) according to the ‘real world’
management of their own patients in general practice. One
important issue in this context is that whilst the CKD classiﬁcation
system is built on progression of renal functioning, the main
clinical management focus is on cardiovascular disease (CVD)
(hence the need for monitoring and control of blood pressure)
(Brady and O'Donoghue, 2010). The laboratory readings used to
determine CKD status (eGFR and proteinuria) are independent
predictors of CVD and mortality from all causes, as well as of renal
disease progression (Matsushita et al., 2010). It is thereby possible
to conceive of scenarios where some patients could become
confused about the management of CVD in CKD, with lay people
potentially more likely to associate kidney ‘problems’ with urinary
functioning.
Critics of the CKD staging model have suggested that the
available scientiﬁc evidence “points to the contrary” and the nat-
ural history of CKD is currently unclear (Onuigbo, 2013). Levels of
one the laboratory values used in CKD staging (eGFR) decline
naturally with age, and thus it has been argued that low results in
elderly people are in fact clinically “normal” (O'Connolly and
Woolfson, 2009). Whilst eGFR is a clinically useful indicator of
kidney functioning, the readings are unreliable, especially in those
with mildly reduced eGFR (stage 1, 2 and 3a CKD) (O'Callaghan
et al., 2011). Thus, there exists the potential for a lack of conﬁ-
dence in the accuracy of eGFR readings in elderly and/or early stage
CKD patients. This holds implications for how GPs manage such
patients, perhaps especially in the context of multimorbidity and/or
polypharmacy. Thus, whilst the evidence-based guidelines advo-
cate tight blood pressure control (including use of ACE inhibitors
for patients with proteinuria), in the elderly GPs might face a trade-
off between the beneﬁts of blood pressure control and the associ-
ated risks of treatment (including an increased risk of falls). The
combination of clinical uncertainties surrounding patients with
mildly reduced eGFR and questions about the risks versus beneﬁts
of tight blood pressure control in the elderly might contribute to an
under-recording of CKD in primary care. Thus, the need to use QOF
templates in CKD holds the potential for a conﬂict between this
incentivised activity and the treatment or management of elderly
patients with mildly impaired kidney functioning. The ﬁndings of
an English representative population survey put the prevalence
rate of CKD (stages 3e5) at 6% (rising to 31% of males and 36% of
females aged 75 and over). The results of this survey point to an
under-recording of the condition by general practices in the UK and
a tendency for patients not to be aware, with less than 2% of men
and womenwith CKD (stages 1e5) reporting having been informed
that they had the condition by a doctor (Roderick et al., 2011).
4. Methods
The main aim of the nested qualitative study was to examine
patients' experiences over time of the devolvement and use of the
CKD self-management programme, interaction with services and
wider social and personal resources and networks. The population
for the qualitative study consisted of a purposive sample of patients
recruited to the BRIGHT trial who all had a diagnosis of CKD Stage 3.The analysis presented in this article is based solely on baseline
interviews, which were broadly concerned with interactions with
health workers, management of health conditions in general and
social networks in peer support. Whilst short follow-up interviews
were undertaken, these did not provide any further insights into
perceptions of diagnostic status or experiences of clinical
communication about CKD. The focus here is on accounts of diag-
nostic disclosure. Some other interviewees in the intervention arm
of the trial were recruited for a separate process evaluation spe-
ciﬁcally of the telephone guidance around community support.
These ﬁndings are reported elsewhere (Blickem et al., 2014).
The overall approach adopted in the nested qualitative study is
best described as a comparative case study approach. The methods
of sampling and data collection were based on elements of
grounded theory (Glaser and Strauss, 1967)dbecause little is
known about patients' views of CKD disclosure. However, bio-
graphical or narrative approaches (Riessman, 1993) characterised
the way that interviews were undertaken and constantly compared
with one another. The aim of the sampling strategy was to achieve
maximum variation in narratives around CKD disclosure. Accord-
ingly, narratives were analysed as data were collected, in constant
comparative manner, in order to target further sub-groups of pa-
tients to be interviewed. Differences in interviewees' awareness of
having CKD was used as a primary framework for the analysis.
The study received NHS ethics committee and local R&D ap-
provals. At the time of recruitment to the main trial, participants
gave consent to be contacted by a researcher to ask if they would
also undertake a face-to-face interview. Of 30 people identiﬁed as
potential recruits to the study, 26 (86.7%) agreed to take part. One
could not be contacted and three refused for various reasons. In-
terviewees were given a £10 shopping voucher at the end of the
interview, which typically lasted for around an hour. All interviews
were conducted by the ﬁrst author and transcribed by a profes-
sional transcription agency.
The ﬁrst ﬁve interviews were used to reﬁne the line of ques-
tioning and allowed the interviewer to ‘test the water’ in relation
to the delicate handling of interviews about a condition that some
interviewees believed they had not been told about, or did not
believe that they had. Efforts were made to achieve an equal
number of interviewees in the control and intervention arms of
the trial and a reasonable gender mix. Interviewees in the inter-
vention arm were asked about the information they had been
given about CKD as part of the BRIGHT trial. Members of the
control group did not receive this information and could not be
questioned about it. They were also not asked about written in-
formation in CKD due to the potential risk of such discussions
leading to ‘contamination’ of the control arm of the trial. The ﬁrst
eleven transcripts were each analysed by both the ﬁrst author and
one of the other authors and theoretical notes and memos were
made using the comment feature in word processing software. The
focus was on the overall narrative in each transcript and the exact
words reported as being used by health workers in relation to
CKD. Later, we compared accounts according to degree of diag-
nostic disclosure and examined the circumstances and attributes
that appeared to be associated (in a conceptual sense) with
disclosure/non-disclosure. Finally, we compared selected and
grounded themes from accounts in a grid (akin to a 2  2 table in
statistical research) setting disclosure status against whether in-
terviewees reported being ‘active’ or ‘passive’ in consultations
with primary health care workers. This framework represented a
conceptual ‘best ﬁt’ to describe the ﬁndings, as commonly used in
grounded theory approaches to qualitative data analysis. Previous
attempts to explain variations in reported disclosure by other
means (e.g. according to length of time since being placed on the
register, presence or absence of comorbidities, attitudes or
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other demographic features) were unsuccessful.
5. Results
5.1. Overview
Twenty-six participants in the BRIGHT trial were recruited to
the nested qualitative study, with equal numbers taken from the
intervention (8 women, 5 men) and control (4 men, 9 women)
arms. The interviewees were elderly, with a mean age of 72 years
(range 59e89, median 71). These ﬁgures were commensurate with
those of the 440 total participants to the BRIGHT trial from which
the sample of interviewees was drawn (mean 72 years, range
40e90, median 72). The interviews revealed that just over half (15/
26) had received a diagnosis of CKD prior to their involvement in
the trial, although the speciﬁcs of the information disclosed varied
considerably (see below). Four people only learnt about the status
of their kidneys as a result of being enrolled into the trial and the
remaining seven perceived that they had still not been informed
that there was anything wrong with their kidneys even in the
context of recruitment to the trial.
5.2. Disclosure, partial disclosure and non-disclosure
Analysis of the accounts revealed thatmost patients' CKD stories
fell into two main types: those who felt that they did not have
anything wrong with their kidneys and those who recognised the
issue but had been reassured that this was nothing for them to
worry about (Table 1). It should be stressed that even some who
had apparently received a ‘full’ disclosure of CKDwere still adamant
that there was nothing wrong with their kidneys. Those who had
been told something about CKD by health workers were compared
on a continuum and 11 (of 19 who were disclosed information)
appeared to have received a partial disclosure whereas 8 described
a fuller disclosure. “Full” disclosure involved patients being
explicitly told that they had “Chronic Kidney Disease” (cases 10, 24,
25, 26); that their kidneys were “failing” (case 6); or, they were
prescribed drugs within a consultation about impaired kidney
functioning (case 16). Two further respondents who were charac-
terised as having a “full” disclosure were informed of impaired
kidney functioning as a result of scans for other health problems in
secondary care (cases 11 and 22).
In some cases, patients were told that theydvariouslyd
“might” (case 17) have a “slight” (case 11) case of “mildly impaired”
kidneys (case 3); ”just on the borderline” (case 4) but that it could
be normal for their age (cases 8 and 11, for example). In other cases,
people reported having been told that their kidney functioning wasTable 1
Overview of patient narratives around CKD diagnosis and disclosure (n ¼ 24).
Main theme Members
I don't have a
problem with
my kidneys
Interviewees 2, 7, 12, 13, 14, 15, 18, 19, 21, 23, 25
It's nothing serious “She just said it was impaired kidneys”
(#1); “Under par” (#3); Nothing to worry about
(#4, #10, #20); Nothing explained, just a ‘casual
remark’ about kidneys (#5, #22); “It's only old age
kidney problems”, “My kidneys are the least of my
problems” (#8); “Just a couple of notches lower than
what they should have been” (#9); “It's probably
your age” (#11); “I was just told that I might have
it” (#17); “Something that they are just keeping
an eye on” (#24); “Nothing serious” (#26)being monitored, usually because of prescription drugs they were
taking, but they nevertheless maintained that there was nothing
wrong. The alternative narrative here, as in cases 19 and 23, was
that there had been only one irregular result in a long series of tests
which constituted a “blip” or “just a one off” sincewhich everything
had been ﬁne (case 19).
Interviewees in the intervention armwere routinely asked what
information people should be given about CKD, and many stated
that doctors should disclose medical information to patients. As
case 20 put it, “I like the truth, come straight out with it, I can deal
with it.” However, when asked, many interviewees, although
disproportionately more elderly women, reported that they would
not even consider asking their GP any questions. Sometimes this
was because of shock but in other accounts it appeared to reﬂect a
view that doctor knows best. Another commonly reported experi-
ence was that people had been told (or not told) different things by
different GPs:
… but I was so shocked anyway, and my, my daughter made an
appointment to see the doctor with me ‘cos she said, “Why
wasn't I informed?” And he… of course the doctor said, “Well, I
naturally thought another doctor had told you.” You see
different doctors and … I suppose they think the previous
doctor's told you. (Case 22: 3: 12-15)
Some of the men interviewed reported being active in engage-
ments with primary care practitioners. It was noted in case 9, a
female retired health worker, that because information about CKD
had been related by the practice nurse, the interviewee construed
this as meaning that the condition was not serious. For case 4, the
asymptomatic nature of CKD, as compared to the symptoms of
other conditions, meant that it was not something that she was
bothered about, neither in terms of information and advice nor
active management:
Respondent: She said “Don't worry it's on the borderline
[inaudible 05:20].” Like that, you know, so I don't know really.
Interviewer: Have you ever been given any advice from your GP
or the, the practice nurse at the GP, about diet or exercise?…
Respondent: Er, well I don't know. I'm more concerned really
about, erm, about the problems I have in myself as I know about.
I mean I know you can have problems that you don't know
about, you know, like diabetes and different things like kidneys,
me kidneys and that. And blood pressure, you know a lot of
people are walking about with it now, you know. But I wonder
more about the, you know, not actually worry, but you know.
Interviewer:… I think when I came before [the interviewer also
visited this and some other interviewees to collect baseline
questionnaire data for the main trial] you mentioned that you
had a few, er, health problems don't you?
Respondent: Yes.
Interviewer: What are the main ones that cause you problems
on a day to day kind of … ?
Respondent: Pain, me, erm, pain, me legs and me back and me
neck, yeah. (Case 4, 4-5: 14-1)
For people with other medical conditions, the prioritisation of
an asymptomatic condition like CKD stage 3 was unlikely given the
possibly troublesome nature of symptoms of other conditions (e.g.
arthritis, diabetes, strokes or heart attacks) and the objective of
many who sought to limit their intake of prescribed drugs.
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with a status quo where doctors led communicative encounters
and patients remained passive. Some patients appeared content to
leave health related matters to medical professionals rather than
bother about things too much themselves. Others were reassured
that in spite of their identiﬁcation as being at “increased risk,” there
was in fact nothing wrong with them and they had nothing to
worry about. However, in the reported absence of medical expla-
nations for their membership of a diagnostic category, some pa-
tients were left to formulate their own explanations. These
commonly centred on the potential of drug treatments themselves
to adversely impact on kidney function. In one particular case (5), a
woman with diabetes attributed a failure to control the condition
with the appearance of a CKD diagnosis, which was linked to pre-
scription drugs used in the treatment of arthritis:
Interviewer: So you've always … been having these tests over
the years, but it was only two months ago that you were told
that there was something wrong?
Respondent: Yes. Because they couldn't control my diabetes.
And he just… it was just a casual remark, it wasn't really much,
he just said, “Er, your kidneysmight be leaking.”No explanation,
no nothing.…Which is so unusual for my doctor because he's a
lovely man. And I just … and I didn't even ask him anything
about it or … I just come away, I just didn't … it just didn't
register.
Interviewer: Is that because you were shocked or …
Respondent: I think so.
Interviewer: … you didn't think it was important, or … ?
Respondent: I think it was because I was shocked.
Interviewer: Okay.…
Respondent: All I know is, um, because I have arthritis, I used to
have regular blood tests because they said the tablets could
affect the kidneys. (Case 5, 3: 6-23)
On occasion, patients had seemingly been told about CKD in
simplistic, informal or ‘lay’ terminology (e.g. that (one of) their
kidney/s “were/was leaking” (cases 4, 5 (above) and 20) or that they
had a “lazy kidney” (e.g. case 13)). It is assumed that this was done
to make things easier for patients to understand, but the effect
seemed to rather be the opposite and those patients who were
bothered about it to any degree were seemingly left to construct
their own fuller explanation. On one of the few occasions when a
patient had been told their results in the form of speciﬁc ﬁgures, the
more detailed informationwas seemingly no help in translating the
disclosure into a form that would have been of use in self-
management terms:
“And, erm one doctor gave me my results, and I can remember
being told last time, ‘You were down a bit, it was 57,’ which
meant nothing to me, I didn't take that on board really, I didn't
take any notice of it, and, ‘But you're ﬁne,’ and no more.” (Case
23: 2: 24-27)
Several patients were insistent that they had nothing wrong
with their kidneys. For case 14, the test result showed that
“everything was ﬁne.” Case 15 was sure that her GP had never used
the word “kidneys” in a consultation. One woman (case 18) was
similarly adamant that she had never been told anything about her
kidneys, although during the course of the interview she did state
that her GP had told her to “drink more” on several occasions. Thiscould suggest that case 18 did indeed have kidney problems,
although her GP had issued health advice without an accompa-
nying diagnostic label. However, case 18 reportedly ignored this
advice and carried on drinking the same amount of ﬂuids that she
has always done, “Because I'm not poorly.” At the end of the
interview, she reﬂected:
“You know, if I was to wake up one morning and think, ‘Oh,
there's something the matter with my waterworks,’ then I
would go to the doctor. But at this moment in time I haven't got
anything wrong. And I really don't knowwhat symptoms to look
out for if I did have kidney disease.” (Case 18: 39: 13-16)5.3. Nondisclosure, trust and the potential for diagnostic burden
Qualitative studies of GPs' attitudes towards CKD have high-
lighted the capacity of the diagnosis to frighten patients (Crinson
et al., 2010), making reassurance a necessary part of diagnostic
disclosure (Blakeman et al., 2012). In the preceding section, we
discovered how apparent attempts at “reassurance” played out, e.g.
via assertions by health workers that CKD stage 3 is “normal” or
“nothing to worry about.” Whereas some patients challenged what
they perceived to be vague or partial information giving, others
articulated trust or conﬁdence in their doctors, or in the health
system, which led them to perceive that CKDwas indeed nothing to
worry about. These themes are reﬂected in the following interview
extract:
Interviewer: When you found out that you might have some-
thing wrongwith your kidneys, was this a shock to you, or was it
something you were concerned about?
Respondent: No, I wasn't unduly concerned because I was, an…
I have full conﬁdence in the health services …
Interviewer: Right.
Respondent: … and I felt that if there was something serious
they would have told me.
Interviewer: Okay. Have you… since all of this has come to light
have you been back to your GP to try and ﬁnd out more or have
you been anywhere else for any … ?
Respondent: I spoke to the nurse about it.
Interviewer: Okay, and what did she tell you?
Respondent: She says well, it's not a … something serious,
you've got a lazy kidney. One's not just up to the standard of the
other one. (Case 13: 2-3: 25e8)
Case 10, was among those who had sought further information
from their practice about CKD following the recruitment pro-
cedures for the trial. Having learned of the diagnosis from a nurse
he reported initially being “worried sick,” and prepared to “go in
and play hell” with his GP. However, following a consultation with
his GP, he was “reassured” that his kidney function was in fact
“normal” and the apparent concealment of monitoring of his kid-
ney functioning (over a period of ten years) was used to bolster the
view that the condition was nothing serious. Here, implicit trust
was being articulated whereby if his GP had believed CKD stage 3
was serious, or something to worry about, then hewould have been
informed earlier. However, such conﬁdence and trust in GPs was
only mentioned by a small number of respondents and seemed
particular to those with longstanding relationships with their
doctor:
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me and I … I just trust them, I think, if anything, er, could be said
that would help me, they would tell me, mm.” (case 24: 20: 16-19).
Following from the above, we suggest that an apparent trust to
“tell me” has been extended to a trust related to not being told
about information that is seen as unimportant. Some of those in the
trial intervention arm were also prompted by a cartoon in the CKD
handbook and stressed that GPs needed to consider whether in-
dividual patients would be able to cope with a “chronic” label that
had the capacity to provoke anxiety or fear of impending death.
However, it was not at all clear from respondents' accounts how
GPs would be able to discern which patients would be able to
handle this potentially disturbing information or not. The potential
capacity of a “fuller” disclosure to frighten individuals, and the role
of reassurance in diagnostic communication around CKD is best
exempliﬁed in case 24 (Box 1), who was the only interviewee who
reported explicitly being told that they had been placed on the
“chronic kidney disease register.”Box 1
Description of a fuller disclosure: fear and reassurance.
Interviewer: Right, okay. So you started at a new, erm, surgery and it was
the, er, the practice nurse who told you. Do you remember exactly what
she said to you?
Respondent: Er, just what I've said to you, when … when I went the
following week for the results of all, you know, the urine sample, the
blood test, etc., etc., she said, er, one of the tests showed that my
kidneys weren't working at full capacity and my doctor had put me on
the kidney disease register so that I would be kept an eye on.
Interviewer: Right. Right, okay, erm, and how did you feel being given that,
er, news?
Respondent: Well, when they said, “kidney disease register,” they
frightened me to death, to be honest! Erm, but when it was explained to
me what it is, I was reassured then.
Interviewer: Right, okay. How did they, erm, reassure you?
Respondent: They told me that it didn't mean I had a chronic illness and I
was going to die in three months, etc., erm, and they were just going to
monitor me at regular intervals, which they have done.
… [Later, during the same interview] …
Interviewer: And have they told you if your result has stayed the same, or
gone up, or down?
Respondent: It's never gone … it's never gone worse.
Interviewer: Right, okay.
Respondent: Erm, a month ago, they were quite pleased with me.
Interviewer: Right.
Respondent: Yeah.
Interviewer: And did … what did … did they say that your result had
improved, or … ?
Respondent: Yeah, they said my kidney function had improved, yeah.
Interviewer: Right, okay. So is it still … are your kidneys still not working
properly then, or have they now gone back to normal?
Respondent: No, they're still not working properly, but I feel perfectly
alright, I'm not aware that … until they told me, I wasn't aware I had a
problem.
Interviewer: And were you given the opportunity to ask any questions, or
did they explain things in a bit more detail about what the implications
of what … of what this might … might be for you?
Respondent: No. No, they didn't elaborate on it.
Interviewer: Would you have liked them to?
Respondent: I don't think so.
Interviewer: Okay.
Respondent: I don't think so, I think, I don't think so, I think, maybe I'd have
worried about it if I'd known a bit more. I can tuck it in the back of my
mind now and just get on with my life and, well, if it becomes a bigger
problem in the future, then, obviously, I will want to know.
(Case 24: 2-4, 24-15)5.4. Disclosure and active communication in medical encounters
The narratives underlined diagnostic disclosure as a temporal
process. In some respects this is not surprising given the need for
continual monitoring at periodic intervals. However, an additional
inﬂuence appeared to be the extent to which patients considered
themselves as ‘active’ communicators in GP and practice nurse
consultations. This seemed to be a feature of 23 of the 26 accounts.
Although the general tendency was towards varying degrees of
non-disclosure, most of those who tended to identify themselves
towards a predominantly passive or receptive stance reported
having had the diagnosis undisclosed, whereas some of those who
identiﬁed themselves with a more active engagement style in
consultations had reportedly received full disclosure.
Case 16, was one patient who had received full disclosure, but he
was unusual in only being aged in his ﬁfties at the time of diagnosis
(and disclosure). He was also unique in that he had volunteered for
a community health screening programme, and this might explain
why he accepted CKD as a lifestyle and prevention issue. This ac-
count was one of two that did not ﬁt the framework represented in
Table 1. He described being very active in interactions with his
doctor, criticised an approach focused on the use of medications
and had successfully negotiated access to a health trainer as an
alternative to prescription drugs. Case 26, a 66 year old man, still
young comparedwithmany other respondents, also appeared as an
active participant in medical encounters, although in his case it was
less clear whether disclosure was rather associated with good
clinical practice (see also below). Finally, Case 25 was an active
communicator aged 69 years who had received full disclosure,
although he had ﬁercely resisted the diagnosis, mainly because he
sought to stop taking blood pressure medication and he felt that a
designation of CKD would limit that possibility.
In those aligned to accounts of more active communication
where the diagnosis had not been revealed it appeared that people
had either been told that there was nothing wrong with their
kidneys (cases 2, 7, 18, 19) or that it was nothing to worry about
(cases 4, 8, 9, 11, 20) (see also Table 1). These interviewees were
older and the majority had a history of numerous conditions/
symptoms or adverse health events (cases 2, 4, 7, 8, 9, 11, 18, 20).
Only one interviewee appeared as a passive communicator who
had a diagnosis revealed. However, her account represented a
deviant case (6) in that she was the only person who had been told
that she was in immediate danger of renal failure. The diagnosis
was linked to arthritis medication which was stopped and changed
to alternative drugs. She was also atypical compared to the rest of
the sample in reporting symptoms perceived to be directly related
to kidney functioning in the form of increased urinary frequency.
Following the CKD diagnosis and change in her prescription drugs,
her kidney functioning was now described as “liveable with… from
what I can gather.” This account was one of two that did not ﬁt the
framework represented in Table 1.
Eight narratives suggested a greater degree of passivity in terms
of communication. These were from people who reported that they
had not had diagnoses revealed to them. Typically, these in-
terviewees reported that they did not ask any questions of their GPs
during consultations e either out of fear, respect, forgetfulness or a
shortage of time e but simply accepted whatever they were told.
An equal number felt that there was nothing wrong with their
kidneys (cases 12, 13, 14, 23) or that the condition was not serious
(cases 1, 3, 5, 17) (see Table 1). Case 23 was unusual compared with
the others in this group in that her younger age (64), former pro-
fessional occupation (teacher) and adherence to a lifestyle/pre-
ventionmodel of health, suggested that shemight rather have been
an active medical consumer who engaged with her GP during
consultations. However, when it came to interactions with her GP,
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paternalistic view that doctor knows best.
5.5. The blocking of nascent opportunities for communication?
One woman (case 15) was absolutely adamant that there was
nothing wrong with her kidneys and denied that her GP had ever
used the word “kidneys” in a consultation. However, she was caring
full time for her disabled husband, who “never leaves that seat” (in
front of the television). The only time she left the house was to visit
the supermarket once aweek as she reported that shewas fearful of
leaving of him. Although shewas diagnosedwith type II diabetes 12
years ago, and was being treated for a thyroid problem, it appeared
as though her medical concerns were focused on her husband, and
in this context, putative engagement with an asymptomatic CKD
stage 3 diagnosis appeared limited. The asymptomatic nature of
CKD meant that it was unlikely to receive priority given more
pressing concerns.
Case 24, was unusual in having received a full disclosure (see
Box 1) and this was linked to the perception that her GP was of the
“good,” “old fashioned” kind (despite being young in age). This
interviewee was the only one explicitly informed that she had been
put on the “chronic kidney disease register.” From her account, it
was unclear whether she could be characterised as having either an
active or passive role in consultations, but the overwhelming
theme rather concerned a perceived lack of meaning of a CKD
diagnosis. Thus, whilst she received “reassurance” from the practice
nurse that this is something “that they are just keeping an eye on,”
she had never been told the detail of her test results and her GP had
himself never discussed CKD with her. She expected more infor-
mation about the meaning and consequences of the diagnosis
which she did not feel were adequately explained. In commonwith
many others, however, and in spite of disclosure, she reported that
she had no symptoms related to her kidneys and thus did not feel
that she had a disease. She expressed the view that disclosure
needs to be done in away that does not include thewords “chronic”
or “disease” which she found alarming. Thus, in this case, it was not
possible to ascertain whether the interviewee was ‘active’ in con-
sultations or not given the material gleaned during the interview.
In the narratives of cases 21 (diagnosis concealed) and 22
(diagnosis revealed, in part) the main issue in the account of con-
sultations related to CKD non-disclosure was the problem of always
seeing a different GP when visiting the practice. In case 22 (a 78
year old woman) partial disclosure was seemingly made by acci-
dent by a different GP to her own doctor, who had told her, “Well
you do know that your kidneys are only working 50%, don't you?”
This news came as a shock. The doctor told her that he assumed
that somebody else had given her the diagnosis as it had been on
her records for the preceding 5 years. In a direct opposite manner,
case 21, who reported always seeing a different doctor when he
visited his GP surgery, reported being explicitly told by one GP that
his kidneys were “perfectly alright.” After the tape recorder had
been switched off, the interviewee suggested that he would have
been told more had he still been seeing his former GPwhowas now
retired. Thus, systems issues could seemingly work for diagnostic
disclosure, or against it, depending on the individual GP seen at
each appointment.
6. Discussion
This study of patient narratives in CKD diagnosis has illustrated
how disclosure practices can play out and are interpreted by (and
have implications for) patients. The ﬁndings of this study suggest
limited or partial disclosure of CKD diagnoses, which resonates
with health professional accounts of CKD disclosure and withprevious sociological observations about the diagnostic process
(see e.g. Blaxter, 1978; Brown, 1995; Jutel and Nettleton, 2011). A
key inﬂuence on the subjective awareness of having CKD related to
the extent to which patients reported being involved, or partici-
pating in, discursive encounters with GPs and practice nurses.
These ﬁndings cast some uncertainty in relation to presumptions
about “shared decision-making” and delivery of lifestyle advice,
which are supposedly linked to the goal of monitoring early stage
CKD in an attempt to limit the future costs and consequences. The
blocking of possibilities for the potential enactment of patient self-
reﬂection and the initiation of self-management activities, e.g. self-
monitoring or seeking further information, sits at odds with the
rationale for screening andmonitoring of CKD in the ﬁrst place. This
tension most importantly points to an apparent disconnect be-
tween clinical activities undertaken for the purposes of “points” or
remuneration and the communication of diagnostic information to
patients.
Patient strategies and self-management practices are predicated
to a large extent on open disclosure and discussion as to the im-
plications of a diagnosis. Two interviewees were found not to ﬁt
with the analytical framework: one much younger than other
participants and onewho had previously reported a history of renal
symptoms. Thus, our results seem to refer mainly to elderly pa-
tients with asymptomatic kidney disease. One limitation was that
data constituted historical accounts of clinical encounters, rather
than observation of actual encounters. These limitations point to
the possibilities of further research, perhaps in the form of surveys
of patient sub-groups and recording or observation of clinical
encounters.
Although patients seemed to need and value reassurance, in the
face of partial or non-disclosure it could result in an over-
trivialisation of the condition or suspicion or rejection of medical
information related to other conditions (data not shown). The ac-
counts of this elderly sample of patients to a large extent reﬂected
traditional expectations of encounters leaning more to a paternal-
istic acceptance of what it is appropriate to expect in encounters
between health professionals and patients. However, this was less
evident in the narrative accounts of younger people and in people
with professional or technical employment histories, including
health care.
Those who subsequently became aware of surveillance and
recording of kidney function in primary care reacted with surprise,
fear and disbelief at learning that they had a “disease” in the
absence of a history of symptoms. The problem it seems with
defaulting to a ‘doctor knows best’ approach is that when patients
were presented with partial information, or facts which were
perceived to have been hidden from them for some time, they were
free to assume that this was in their best interests. For some, ten-
sions, conundrums and paradoxes were then thrown up about their
health, the aetiology and symptoms of other health conditions and
their relationship with their GP.
Health professionals form a part of the self-management life-
world of patients as part of a recursive relationship between the
clinic and condition management in everyday domestic settings,
with inputs from a wide range of relationships within personal
communities (Rogers et al., 2007). From a clinical perspective non-
disclosure may offer beneﬁts in simultaneously removing the need
for both illness and treatment burden. However, for patients non-
disclosure brings to the fore the potential denial of an equality of
knowing what is being recorded about them and what health
professionals know about their kidney functioning. Non-disclosure
may also remove an added rationale for taking self-management
action (e.g. through self-monitoring of blood pressure or adher-
ence to medication). In this respect the ﬁndings of this study also
reﬂect those of medical non-disclosure practices in other
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to cause suffering within the cultural practices of biomedicine
(after Gordon and Paci, 1997).
The example of early stage CKD has afforded an opportunity to
assess the impact on patients of emerging or contested or ‘pre’
disease categories. The variation in reported disclosure practices, as
described by patients, would seem to suggest that being given a
diagnosis is in some ways a matter of fate or luck, much as disease
and illnesses tend to be in lay epidemiological terms (Davison et al.,
1991). However, even though variations in physicians' practice
seemed pre-eminent across patients' accounts, there were also
differences in patients' awareness of their own diagnostic status
according to the degree to which they had engaged with clinicians
over matters of screening, testing and diagnosis. Screening for
conditions has increasingly blurred the boundaries between dis-
ease and risk of disease (Aronowitz, 2009), e.g. as in pre-diabetes.
A longitudinal qualititative study of review consultations for
patients with long-term conditions, found that the QOF has rein-
forced a “biomedical agenda” where patients' management needs
can be denigrated in favour of clinical surveillance (Chew-Graham
et al., 2013). As with historical studies of primary care consulta-
tions, the patient agenda can be ignored (e.g. Stevenson et al.,
2000). Thus, the QOF has the capacity to “socialize patients into
becoming passive subjects of ‘surveillance’” (Chew-Graham et al.,
2013). These issues were clearly evident in accounts' of CKD
disclosure in primary care (itself a QOF performance indicator)
which also point to issues of trust and ‘conﬁdence’ in diagnostic
disclosure and non-disclosure. Identifying and recording a diag-
nosis of CKD relates to a ‘logic’ of population based medicine
(extending healthy lives of vulnerable population groups) (see also
McDonald et al., 2013). However, the latter was not related to the
dimensions of organisational activity operating in primary care
about CKD. At the time of the study recording was oriented to the
pay for performance critieria in primary care which did not inter-
face with the arrangements or ethos for public health. Whilst a
public health focus is a logical focus of CKDmonitoring, the ’pay for
performance’ arrangements appear to take precedence.
The ﬁndings of this qualitative study of patients' perceptions of
CKD highlight challenges for the enactment of public health pol-
icies and strategies in relation to patient empowerment and shared
decision-making in long-term condition management. To some
extent the ﬁndings here resonate with a long standing literature
about doctor-patient communication concerning medications in
primary care, where minimal opportunities for shared decision-
making are not uncommon and are associated with a traditional
paternalistic model (Stevenson et al., 2000; Barry et al., 2001).
However, the more recent public policy of ‘pay for performance’ in
General Practice brings with it new systems and incentives for
monitoring and recording of symptoms and health outcomeswhich
are principally directed atdand fordthe beneﬁt of the smooth and
successful operation of primary care organisations. In particular
this sets up new imperatives which have the capacity to increase
tension inside a framework that pre-supposes that patients
candthrough contact with primary health care professionalsd-
make the lifestyle and other changes necessary to improve their
individual health. These tensions emanate from the increased use
of electronic patient record systems, templates for medical con-
sultations, payment for undertaking tasks or reaching targets and
increased use of clinical guidelines for management or treatment.
The ﬁndings of this study concerning CKD in primary care lead us to
question whether the kinds of structural changes referred to have
enhanced or rather limited the opportunities for more involvement
of patients in their own care. The ‘competing logics’ of population-
based medicine and medical professionalism already present
challenges for medical practice in primary care (McDonald et al.,2013). Early stage CKD seems to encapsulate such competing
challenges and begs questions about whether instrumental ‘evi-
dence-based’ solutions constructed at the population level are
compatible with the individual enactment of self-management of
risks of possible future ill health burdens.
Acknowledgements
The study described in this article was funded by the NIHR
Collaboration for Leadership in Applied Health Research and Care
(CLAHRC) for Greater Manchester. The views expressed are those of
the authors and not those of the NHS, the NIHR or the Department
of Health.
References
Armstrong, D., 2011. Diagnosis and nosology in primary care. Soc. Sci. Med. 73,
801e807.
Aronowitz, R.A., 2009. The converged experience of risk and disease. Millbank Q. 87
(2), 417e442.
Barry, C.A., Stevenson, F.A., Britten, N., Barber, N., Bradley, C.P., 2001. Giving a voice
to the lifeworld. More humane, more effective medical care? A qualitative study
of doctor-patient communication in general practice. Soc. Sci. Med. 53,
487e505.
Blakeman, T., Protheroe, J., Chew-Graham, C., Rogers, A., Kennedy, A., 2012. Un-
derstanding the management of early-stage chronic kidney disease in primary
care: a qualitative study. Br. J. Gen. Pract. 62 (597), e233ee242.
Blaxter, M., 1978. Diagnosis as category and process: the case of alcoholism. Soc. Sci.
Med. 12, 19e25.
Blickem, C., Blakeman, T., Kennedy, A., et al., 2013. Study protocol: the clinical and
cost-effectiveness of the BRinging Information and Guided Help Together
(BRIGHT) intervention for the self-management support of people with stage 3
chronic kidney disease in primary care: study protocol for a randomized
controlled trial. Trials 14, 28. http://dx.doi.org/10.1186/1745-6215-14-28.
Blickem, C., Kennedy, A., Jariwala, P., et al., 2014. Aligning everyday life priorities
with people's self-management support networks: an exploration of the work
and implementation of a needs-led telephone support system. BMC Health
Serv. Res. 14 (1), 262. http://dx.doi.org/10.1186/1472-6963-14-262.
Brady, M., O'Donoghue, D., 2010. The role of primary care in managing chronic
kidney disease. Br. J. Gen. Pract. 63, 173e174.
Brown, P., 1995. Naming and framing: the social construction of diagnosis and
illness. J. Health Soc. Behav. (Special issue), 34e52.
Bugge, C., Entwistle, V.A., Watt, I.S., 2006. The signiﬁcance for decision-making of
information that is not exchanged by patients and health professionals during
consultations. Soc. Sci. Med. 63, 2065e2078.
Calnan, M., Sanford, E., 2004. Public trust in health care: the system or the doctor?
Qual. Saf. Health Care 13, 92e97.
Chew-Graham, C.A., Hunter, C., Langer, S., et al., 2013. How QOF is shaping primary
care review consultations: a longitudinal qualitative study. BMC Fam. Pract. 14,
103. http://dx.doi.org/10.1186/1471-2296-14-103.
Crinson, I., Gallagher, H., Thomas, N., de Lusignan, S., 2010. How ready is general
practice to improve quality in chronic kidney disease? A diagnostic analysis. Br.
J. Gen. Pract 60, 403e409.
Davison, C., Davey Smith, G., Frankel, S., 1991. Lay epidemiology and the prevention
paradox: the implications of coronary candidacy for health education. Sociol.
Health Illn. 13, 1e19.
De Lusignan, S., Gallagher, H., Stevens, P., et al., 2011. Chronic Kidney Disease:
Frequently Asked Questions [Internet]. NHS Employers and the General Prac-
titioners Committee (GPC) of the British Medical Association (BMA). http://
www.nhsemployers.org/SiteCollectionDocuments/Chronic_kidney_disease_
FAQs%20-%20ja040711.pdf (accessed 13.03.13.).
Dennis, S., Zwar, N., Grifﬁths, R., Roland, M., Harris, M., Hasan, I., Davies, G.P., 2008.
Chronic disease management in primary care: from evidence to policy. Med. J.
Aust. 188 (8 Suppl.), S53eS56.
Department of Health, 2012. Liberating the NHS: No Decision About me, Without
me. Further consultation on proposals to secure shared decision-making.
[Internet] url: http://www.gov.uk/government/uploads/system/uploads/
attachment_data/ﬁle/216980/liberating-the-nhs-no-decision-about-me-
without-me-government-response.pdf (accessed 21.08.13.).
eGuidelines.co.uk, 2014. QOF Clinical Indicators 2013/14: Summary
Tables [Internet] Source. http://www.eguidelines.co.uk////eguidelinesmain/
external_guidelines/qof.php?&hcp¼professional#.UzQRRXcbAiw (accessed
27.03.14.).
Elwyn, G., Edwards, A., Kinnersley, P., 1999. Shared decision-making in primary
care: the neglected second half of the consultation. Br. J. Gen. Pract. 49,
477e482.
Faden, R.R., Becker, C., Lewis, C., Freeman, J., Faden, A.I., 1981. Disclosure of infor-
mation to patients in medical care. Med. Care 19 (7), 718e733.
Fraser, S.D.S., Roderick, P., Bailey, L., Sanderson, H., 2012. Novel use of a combined
primary and secondary care data resource: investigation of inequalities in
G. Daker-White et al. / Social Science & Medicine 131 (2015) 31e39 39chronic kidney disease identiﬁcation in the UK Hampshire Health Record.
Lancet 380, S40. http://dx.doi.org/10.1016/S0140-6736(13)60396-7.
Gilson, L., 2003. Trust and the development of health care as a social institution.
Soc. Sci. Med. 56, 1453e1468.
Glaser, B., Strauss, A., 1967. The Discovery of Grounded Theory. Aldine Publishing
Company, Chicago.
Gordon, D.R., Paci, E., 1997. Disclosure practices and cultural narratives: under-
standing concealment and silence around cancer in Tuscany, Italy. Soc. Sci. Med.
44, 1433e1452.
Howson, A., 1998. Surveillance, knowledge and risk: the embodied experience of
cervical screening. Health 2, 195e215.
Jutel, A., Nettleton, S., 2011. Introduction: towards sociology of diagnosis: reﬂections
and opportunities. Soc. Sci. Med. 73, 793e800.
Kiesler, D.J., Auerbach, S.M., 2006. Optimal matches of patient preferences for in-
formation, decision-making and interpersonal behaviour: evidence, models and
interventions. Patient Educ. Couns. 61, 319e341.
Lester, H., Sharp, D.J., Hobbs, F.D.R., Lakhani, M., 2006. The quality and outcomes
framework of the GMS contract: a quiet evolution for 2006. Br. J. Gen. Pract. 56,
244e246.
Matsushita, K., van der Velde, M., Astor, B.C., Woodward, M., Levey, A.S., et al., 2010.
Association of estimated glomerular ﬁltration rate and albuminuria with all-
cause and cardiovascular mortality in general population cohorts: a collabo-
rative meta-analysis. Lancet 375, 2073.
McDonald, R., Cheraghi-Sohi, S., Bayes, S., Morris, R., Kai, J., 2013. Competing and
coexisting logics in the changing ﬁeld of English general medical practice. Soc.
Sci. Med. 93, 47e54.
Mishra, A., 1996. Organizational responses to crisis: the centrality of trust. In:
Kramer, R.M., Tyler, T.R. (Eds.), Trust in Organizations: Frontiers of Theory and
Research. Sage, Thousand Oaks, CA, pp. 261e287.
Moynihan, R., Glassock, R., Doust, J., 2013. Chronic kidney disease controversy: how
expanding deﬁnitions are unnecessarily labelling many people as diseased. BMJ
347. http://dx.doi.org/10.1136/bmj.f4298.
NICE National Collaborating Centre for Chronic Conditions, 2008. Chronic KidneyDisease: Early Identiﬁcation and Management of Chronic Kidney Disease in
Adults in Primary and Secondary Care (NICE Clinical Guideline 73) [Internet].
http://www.nice.org.uk/nicemedia/live/12069/42117/42117.pdf (accessed
13.03.13.).
Onuigbo, M.A.C., 2013. The CKD enigma with misleading statistics and myths about
CKD, and conﬂicting ESRD and death rates in the literature: results of a 2008 US
population-based cross-sectional CKD outcomes analysis. Ren. Fail. 35 (3),
338e343.
O'Callaghan, C.A., Shine, B., Lasserson, D.S., 2011. Chronic kidney disease: a large-
scale population-based study of the effects of introducing the CKD-EPI for-
mula for eGFR reporting. BMJ Open 2011 (1), e000308. http://dx.doi.org/
10.1136/bmjopen-2011-000308.
O'Connolly, J.O., Woolfson, R.G., 2009. A critique of clinical guidelines for detection
of individuals with chronic kidney disease. Nephron Clin. Pract. 111, c69ec73.
Polkinghorne, K.R., 2011. Controversies in chronic kidney disease staging. Clin.
Biochem. Rev. 32, 55e59.
Riessman, C.K., 1993. Narrative Analysis. Sage, Newbury Park, CA.
Roderick, P., Roth, M., Mindell, J., 2011. Prevalence of chronic kidney disease in
England: ﬁndings from the 2009 Health Survey for England. J. Epidemiol.
Community Health 65, A12. http://dx.doi.org/10.1136/jech.2011.143586.26.
Rogers, A., Lee, V., Kennedy, A., 2007. Continuity and change? Exploring reactions to
a guided self-management intervention in a randomised controlled trial for IBS
with reference to prior experience of managing a long term condition. Trials 8,
6. http://dx.doi.org/10.1186/1745-6215-8-6.
Stevenson, F.A., Barry, C.A., Britten, N., Barber, N., Bradley, C.P., 2000. Doctor-patient
communication about drugs: the evidence for shared decision making. Soc. Sci.
Med. 50, 829e840.
Taal, M.W., 2012. Screening for chronic kidney disease: preventing harm or harming
the healthy? PLoS Med. 9 (11), e1001345. http://dx.doi.org/10.1371/
journal.pmed.1001345.
Trachtenberg, F., Dugan, E., Hall, M.A., 2005. How patients' trust relates to their
involvement in medical care. J. Fam. Pract. 54, 344e352.
